What's the Status and Potential Utility of Cabozantinib in Lung Cancer?
Article
Dr. Heather Wakelee of Stanford University Medical Center discusses whether or not cabozantinib - a drug already approved for thyroid cancer - can help patients with lung cancer. February 2014.
[powerpress]